II.2.2) Additional CPV code(s)
II.2.3) Place of performance
Main site or place of performance:
Bassetlaw, North Nottinghamshire
II.2.4) Description of the procurement
The purpose of the Bassetlaw Ophthalmology Clinical Assessment and Treatment Service (CATS) is to improve access and patient experience of common ophthalmic conditions, promote awareness and understanding to improve self-care and treatment for patients with long term ophthalmic conditions and improve the health and well-being of Bassetlaw residents. The Ophthalmology CATS will possess clinical autonomy and a reputation for the delivery of a high quality and clinically safe service.
The service will operate as 2 parts:
— a specialist-led service offering triage, assessment and treatment of a range of ophthalmic conditions. Patients will be referred into the service from other health professionals typically the patient’s registered GP or their optometrist,
— a service which offers diagnosis and management of patients with; cataracts, glaucoma/suspected glaucoma, YAG, general/oculoplastics, medical retina, macular conditions and wet AMD. Management of patients defined as “stable” will reflect the national guidance set out with the NICE guidance and SYB CfO policy.
The Bassetlaw Ophthalmology CATS will:
— provide a “One Stop Shop” service for patients with common (non-urgent/sight threatening) ophthalmic conditions. The CATS will provide patient centred consultations that will deliver diagnostic tests and interventions at the point of contact. This method of “One Stop Shop” will ensure patient care is effectively delivered through a minimum number of patient contacts. Follow up ratios will need to exceed an average of 1:1,
— provide ongoing glaucoma care within community settings,
— provide simple procedures as detailed in the Appendix, in a safe clinical environment,
— provide an expert multidisciplinary opinion for patients referred by their GPs or optometrists, offering an alternative to direct referrals to an outpatient consultant clinic,
— screen for remedial conditions and refer patients as appropriate,
— wet age-related macular degeneration injections,
— conduct clinical assessment, organise diagnostic investigations, provide advice and treatment; inform and educate patients and GPs,
— facilitate referral, where necessary, to other primary or secondary care services with agreed referral processes in place which are understood by all,
— support the development of robust systems for monitoring and clinical audit.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 36
This contract is subject to renewal: Yes
Description of renewals:
The contract will be for a term of 3 years with the opportunity to extend for 12 months subject to mutual agreement between the successful bidder and the Authority. The maximum term of contract is consequently 4 years.
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
II.2.11) Information about options
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: